跳至主要内容
临床试验/NCT05293262
NCT05293262已完成不适用

Definitive Endourological Interventions for Urolithiasis Management During COVID19- Outcomes From a Cohort Study

Roxanne Teo1 个研究点 分布在 1 个国家目标入组 158 人开始时间: 2020年1月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
158
试验地点
1
主要终点
Length of hospital stay

研究概览

简要总结

Guidelines for endourological procedures during COVID-19 have suggested deferring all elective procedures, while obstructed/ infected stones should undergo urgent decompression.

At our centre, screening protocols were implemented with prioritization strategies so that elective care could safely continue at deescalated rates. COVID or septic patients underwent emergency decompression, while non-COVID and non-septic patients underwent primary ureteroscopy (URS) or retrograde intrarenal surgery (RIRS).

We aim to report our experience with endourological surgery for stone disease during COVID-19.

详细描述

We conducted a retrospective review of a prospectively maintained database of all endourological surgeries for stones in our centre during the first wave of COVID19.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Length of hospital stay

时间窗: From admission to discharge from hospital, up to 3 months

Length of hospital stay

Complication rate

时间窗: From admission up to 3 months post operatively

Complications as defined by Clavien Dindo classification system

Stone free rate

时间窗: At follow up visit in clinic 3 months post procedure

次要结局

  • Readmission rate(From discharge up to three months post operatively)

研究者

发起方
Roxanne Teo
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Roxanne Teo

Medical Officer

National University Health System, Singapore

研究点 (1)

Loading locations...

相似试验